MONTREAL, Aug. 27, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has submitted a supplemental application to ANVISA, the Brazilian health regulatory agency, seeking approval for an additional indication for MINJUVI® (tafasitamab) in combination with lenalidomide added to R-CHOP (rituximab,…
Dr. Bonnie Henry, B.C.'s provincial health officer, said it is not too late to make sure children's vaccinations are up-to-date as they head back-to-school.
Ghana has been selected as one of eight countries worldwide to pilot a World Health Organization (WHO) benchmarking tool designed to assess and strengthen institutional capacity for conducting…
Gilead Sciences' HIV treatment arsenal is getting bigger. The leading drugmaker in the four-decade epidemic gained another FDA stamp of approval on Thursday. This time, Gilead will market ...
